Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 20/20 | 0.62 |
| ▸ | BCR | P11274 | 19/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3398529 | 0.91 | ABL1 (0.47) | ABL1BCR | |
| SCHEMBL3400145 | 0.90 | ABL1 (0.76) | ABL1BCRKDM4EMAPTMAPK1 | |
| SCHEMBL3395318 | 0.87 | ABL1 (0.61) | ABL1BCRKDM4EMAPTMAPK1 | |
| SCHEMBL3401859 | 0.81 | ABL1 (0.52) | ABL1BCR | |
| SCHEMBL3397912 | 0.80 | ABL1 (0.61) | ABL1BCRMAPT | |
| SCHEMBL3400278 | 0.80 | ABL1 (0.80) | ABL1BCRKDM4EMAPTMAPK1 | |
| SCHEMBL3400309 | 0.79 | ABL1 (0.48) | ABL1BCR | |
| SCHEMBL29533367 | 0.79 | ABL1 (0.79) | ABL1BCRKDM4EMAPTMAPK1 | |
| SCHEMBL16363365 | 0.79 | ABL1 (0.79) | ABL1BCRKDM4EMAPTMAPK1 | |
| SCHEMBL16127577 | 0.78 | ABL1 (0.77) | ABL1BCRKDM4EMAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2222162-A2 | SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE | Dana Farber Cancer Institute (US) | 2010-09-01 | — | — | EP | claimed |
| WO-2009073153-A2 | SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE | DANA FARBER CANCER INSTITUTE (US) | 2009-06-11 | — | — | WO | claimed |